In ANCA-associated vasculitis, avacopan was superior to prednisone taper for sustained remission
- PMID: 34224265
- DOI: 10.7326/ACPJ202107200-079
In ANCA-associated vasculitis, avacopan was superior to prednisone taper for sustained remission
Abstract
Jayne DRW, Merkel PA, Schall TJ, et al. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021;384:599-609. 33596356.
Comment on
-
Avacopan for the Treatment of ANCA-Associated Vasculitis.N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386. N Engl J Med. 2021. PMID: 33596356 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources